|
Age (y)
|
54±12
|
53±10
|
55±10
|
|
Sex
| | | |
|
Male
|
16
|
28
|
44
|
|
Female
|
0
|
2
|
2
|
|
Body Surface Area (kg/m2)
|
1.91±0.33
|
1.96±0.2
|
1.97±0.18
|
|
Systolic blood pressure (mmHg)
|
131±32
|
128±28
|
133±28
|
|
Diastolic blood pressure (mmHg)
|
83±22
|
85±22
|
84±20
|
|
Heart Rate (min-1)
|
73±18
|
73±13
|
75±16
|
|
Diabetes mellitus (%)
|
19%
|
13%
|
15%
|
|
Current or ex-smoker (%)
|
44%
|
67%
|
59%
|
|
Hypertension (%)
|
38%
|
37%
|
37%
|
|
Time from symptoms to reperfusion (hours)
|
3.5±2.6
|
3.4±3.0
|
3.5±2.6
|
|
Peak Creatinine kinase (IU/L)
|
2216±1994
|
1775±1581
|
2240±2034
|
|
Peak Troponin I (μg/L)
|
65.0±78.7
|
63.6±92.2
|
64±80
|
|
Culprit coronary artery (%)
| | | |
|
Left anterior descending
|
56
|
53
|
54
|
|
Circumflex artery
|
6
|
17
|
13
|
|
Right coronary
|
38
|
30
|
33
|
|
TIMI flow Pre-PPCI (%)
| | | |
|
Grade 0
|
94
|
80
|
85
|
|
Grade I
|
6
|
3
|
9
|
|
Grade II
|
0
|
7
|
4
|
|
Grade III
|
0
|
0
|
0
|
|
TIMI flow Post-PPCI (%)
| | | |
|
Grade II
|
6
|
0
|
4
|
|
Grade III
|
63
|
100
|
96
|
|
Discharge medication (%)
| | | |
|
Aspirin
|
100
|
100
|
100
|
|
Clopidogrel
|
96
|
96
|
96
|
|
Beta blocker
|
94
|
90
|
92
|
|
Ca2+ channel blocker
|
6
|
0
|
2
|
|
Angiotensin converting enzyme inhibitor
|
98
|
94
|
96
|
|
Statin
|
98
|
98
|
98
|
